Data gathered: April 6
AI Stock Analysis - Abbott Laboratories (ABT)
Analysis generated October 15, 2024. Powered by Chat GPT.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. It was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it is now a diversified healthcare giant with a market leading position in several domains such as diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Known for innovation and a strong portfolio of products, Abbott Laboratories has a significant impact on global healthcare markets.
Stock Alerts - Abbott Laboratories (ABT)
 |
Abbott Laboratories | April 4 Price is down by -5% in the last 24h. |
|
Abbott Laboratories | March 8 Insider Alert: Earnhardt Lisa D is selling shares |
|
Abbott Laboratories | March 7 Josh Gottheimer (member of U.S. congress) is buying shares |
|
Abbott Laboratories | March 5 Insider Alert: Shroff Eric is selling shares |
Alternative Data for Abbott Laboratories
About Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
| Price | $124.44 |
| Target Price | Sign up |
| Volume | 10,780,000 |
| Market Cap | $216B |
| Year Range | $103.72 - $140.22 |
| Dividend Yield | 1.9% |
| PE Ratio | 16.29 |
| Analyst Rating | 87% buy |
| Earnings Date | April 16 '25 |
| Industry | Health Care Services |
In the news
 |
Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals?April 4 - Yahoo |
 |
Here’s What to Expect From Abbott Laboratories’ Next Earnings ReportApril 4 - Biztoc.com |
|
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?April 3 - Yahoo |
|
Reasons to Add ABT Stock to Your Portfolio Right NowApril 3 - Yahoo |
|
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified StocksApril 3 - Yahoo |
|
Abbott (ABT) Stock Moves -0.23%: What You Should KnowApril 3 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 10.6B | 8.06B | 2.58B | 1.65B | 2.33B | 1.210 |
| Q2 '24 | 10.4B | 8.01B | 2.37B | 1.3B | 2.14B | 1.140 |
| Q1 '24 | 9.82B | 7.9B | 1.92B | 1.23B | 2.05B | 0.980 |
| Q4 '23 | 10.1B | 8.26B | 1.8B | 1.59B | 2.44B | 1.190 |
| Q3 '23 | 9.99B | 7.82B | 2.16B | 1.44B | 2.33B | 1.140 |
Insider Transactions View All
| Earnhardt Lisa D filed to sell 71,928 shares at $136.6. March 7 '25 |
| Earnhardt Lisa D filed to sell 71,928 shares at $133.8. March 7 '25 |
| MCCOY JOHN A. JR. filed to sell 21,061 shares at $138.2. March 4 '25 |
| Moreland Mary K filed to sell 95,583 shares at $138.2. March 4 '25 |
| Shroff Eric filed to sell 31,970 shares at $138.2. March 4 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
HCA HealthcareHCA |
$331.65 0% | 44 |
 |
Cardinal HealthCAH |
$129.63 0% | 38 |
 |
Henry ScheinHSIC |
$65.47 0% | 42 |
 |
Idexx LaboratoriesIDXX |
$393.73 0% | 45 |
 |
LabCorpLH |
$225 0% | 63 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Mar 7, 25 | Buy | $1K - $15K |
| Emily Randall |
Feb 12, 25 | Sell | $1K - $15K |
| Josh Gottheimer |
Feb 11, 25 | Buy | $1K - $15K |
Read more about Abbott Laboratories (ABT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Abbott Laboratories?
The Market Cap of Abbott Laboratories is $216B.
What is Abbott Laboratories' PE Ratio?
As of today, Abbott Laboratories' PE (Price to Earnings) ratio is 16.29.
When does Abbott Laboratories report earnings?
Abbott Laboratories will report its next earnings on April 16 '25.
What is the current stock price of Abbott Laboratories?
Currently, the price of one share of Abbott Laboratories stock is $124.44.
How can I analyze the ABT stock price chart for investment decisions?
The ABT stock price chart above provides a comprehensive visual representation of Abbott Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Abbott Laboratories shares. Our platform offers an up-to-date ABT stock price chart, along with technical data analysis and alternative data insights.
Does ABT offer dividends to its shareholders?
Yes, Abbott Laboratories (ABT) offers dividends to its shareholders, with a dividend yield of 1.9%. This dividend yield represents Abbott Laboratories' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Abbott Laboratories in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Abbott Laboratories?
Some of the similar stocks of Abbott Laboratories are HCA Healthcare, Cardinal Health, Henry Schein, Idexx Laboratories, and LabCorp.
.